BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3822223)

  • 1. [Diagnostic contribution of the determination of CEA, pH, glucose and lactase dehydrogenase in the pleural fluid in patients with mesothelioma].
    Rapellino M; Borasio P; Baldi S; Coni F; Oliaro A; Libertucci D; Ardissone F
    Minerva Med; 1987 Mar; 78(5):317-9. PubMed ID: 3822223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of pleural fluid carcinoembryonic antigen estimation in the diagnosis of malignant tumours of the pleural cavity.
    Hesdorffer C; Derman DP; Bezwoda WR
    S Afr Med J; 1984 Jul; 66(2):54-6. PubMed ID: 6740425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
    Mezger J; Lamerz R; Permanetter W
    J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].
    Mezger J; Lamerz R; Bresgen M; Schulz A; Berghäuser KH; Liewald F; Sunder-Plassmann L; Häussinger K; Wilmanns W
    Dtsch Med Wochenschr; 1991 Feb; 116(6):207-11. PubMed ID: 1993432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carcinoembryonic antigen in pleural effusion. Adenocarcinoma versus mesothelioma].
    Supervía A; Guitart AC; Rubio J; Cornudella R
    Rev Clin Esp; 1992 Feb; 190(2):69-71. PubMed ID: 1561440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant diffuse pleural mesothelioma confirming diagnosis].
    Calavrezos A; Hain E
    Dtsch Med Wochenschr; 1982 Jun; 107(23):903-6. PubMed ID: 7084057
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis of pleural mesotheliomas].
    Kokkola K
    Duodecim; 1976; 92(6):294-7. PubMed ID: 1261443
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of the assay of pleural carcinoembryonic antigen for the diagnosis of neoplastic pleurisy. Correlation with plasma levels and anatomopathological results].
    Kasparian P; Saillard P; Guibout P
    Sem Hop; 1983 Oct; 59(39):2678-82. PubMed ID: 6316520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.
    Faravelli B; D'Amore E; Nosenzo M; Betta PG; Donna A
    Cancer; 1984 Mar; 53(5):1194-7. PubMed ID: 6362839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
    Pettersson T; Fröseth B; Riska H; Klockars M
    Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemistry of the pleural fluid and the diagnosis of malignant pleurisy].
    Miguères J; Jover A; Vert E; Brouchet A
    Poumon Coeur; 1967; 23(9):1149-51. PubMed ID: 4176462
    [No Abstract]   [Full Text] [Related]  

  • 14. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
    Dejmek A; Hjerpe A
    Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the significances of ratio of pleural fluid glucose to blood glucose.
    Chavalittamrong B; Pongpipat D; Tuchinda M
    J Med Assoc Thai; 1984 Jan; 67(1):16-20. PubMed ID: 6716022
    [No Abstract]   [Full Text] [Related]  

  • 16. Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.
    Mezger J; Calavrezos A; Drings P; Gatzemeier U; Kaukel E; Konietzko N; Koschel G; Lamerz R; von Pawel J; Römer W
    Lung; 1994; 172(3):183-4. PubMed ID: 8201832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of the detection and determination of hyaluronic acid in the diagnosis of pleural mesothelioma].
    Degand P; Boersma A; Muh JP; Tacquet A; Havez R
    Rev Tuberc Pneumol (Paris); 1972; 36(1):119-26. PubMed ID: 5047497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of combining detection of E-cadherin, carcinoembryonic antigen, and calretinin in cytological differential diagnosis of serous effusion].
    Su XY; Li GD; Liu HB; Jiang LL
    Ai Zheng; 2004 Oct; 23(10):1185-9. PubMed ID: 15473932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pleural mesothelioma: experience with 62 cases in 9 years].
    Villena Garrido V; López Encuentra A; Echave-Sustaeta J; Alvarez Martínez C; Rey Terrón L; Sotelo MT; Ballestín C
    Arch Bronconeumol; 2004 May; 40(5):203-8. PubMed ID: 15117619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of malignant pleural effusion.
    Hausheer FH; Yarbro JW
    Cancer Metastasis Rev; 1987; 6(1):23-40. PubMed ID: 2439221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.